Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions AN Bhatt, A Kumar, Y Rai, N Kumari, D Vedagiri, KH Harshan, ... Life sciences 295, 120411, 2022 | 42 | 2022 |
Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential D Gupta, H Parthasarathy, V Sah, D Tandel, D Vedagiri, S Reddy, ... Virus Research 305, 198555, 2021 | 36 | 2021 |
Easing diagnosis and pushing the detection limits of SARS-CoV-2 U Kiran, CG Gokulan, SK Kuncha, D Vedagiri, BT Chander, AV Sekhar, ... Biology Methods and Protocols 5 (1), bpaa017, 2020 | 16 | 2020 |
mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication events MK Johri, HV Lashkari, D Gupta, D Vedagiri, KH Harshan Journal of General Virology 101 (1), 86-95, 2020 | 15 | 2020 |
Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections D Vedagiri, D Gupta, A Mishra, G Krishna, M Bhaskar, V Sah, A Basu, ... Journal of Virology 95 (21), e01216-21, 2021 | 9 | 2021 |
A unique phosphorylation-dependent eIF4E assembly on 40S ribosomes co-ordinated by hepatitis C virus protein NS5A that activates internal ribosome entry site translation S Panda, D Vedagiri, TS Viveka, KH Harshan Biochemical Journal 462 (2), 291-302, 2014 | 8 | 2014 |
Unconventional MAPK-GSK-3β Pathway Behind Atypical Epithelial-Mesenchymal Transition In Hepatocellular Carcinoma S Parveen, D Vedagiri, HG Nair, H Parthasarathy, KH Harshan Scientific reports 7 (1), 8842, 2017 | 5 | 2017 |
An atypical system for studying epithelial-mesenchymal transition in hepatocellular carcinoma D Vedagiri, HV Lashkari, AS Mangani, JM Kumar, J Jose, AR Thatipalli, ... Scientific reports 6 (1), 1-13, 2016 | 5 | 2016 |
An inexpensive RT-PCR endpoint diagnostic assay for SARS-CoV-2 using nested PCR: direct assessment of detection efficiency of RT-qPCR tests and suitability for surveillance JN Davda, K Frank, S Prakash, G Purohit, DP Vijayashankar, D Vedagiri, ... BioRxiv, 2020.06. 08.139477, 2020 | 4 | 2020 |
Equine immunoglobulin fragment F (ab’) 2 displays high neutralizing capability against multiple SARS-CoV-2 variants D Gupta, F Ahmed, D Tandel, H Parthasarathy, D Vedagiri, V Sah, ... Clinical Immunology 237, 108981, 2022 | 3 | 2022 |
Regulation of EIF2α Phosphorylation by MAPKs Influences Polysome Stability and Protein Translation S Parveen, H Parthasarathy, D Vedagiri, D Gupta, HG Nair, KH Harshan bioRxiv, 2021.08. 30.458160, 2021 | 2 | 2021 |
Development of Equine Immunoglobulin Fragment F(ab’)2 with High Neutralizing Capability against SARS-CoV-2 D Gupta, F Ahmed, D Tandel, H Parthasarathy, D Vedagiri, V Sah, ... BioRxiv, 2021.03. 09.434030, 2021 | 2 | 2021 |
Correction for Vedagiri et al.,“Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections” D Vedagiri, D Gupta, A Mishra, G Krishna, M Bhaskar, V Sah, A Basu, ... Journal of Virology 96 (2), e01822-21, 2022 | | 2022 |
Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections (vol 95, e01216-21, 2021) D Vedagiri, D Gupta, A Mishra, G Krishna, M Bhaskar, V Sah, A Basu, ... JOURNAL OF VIROLOGY 96 (2), 2022 | | 2022 |